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Hyperhomocysteinemia activates NF-jB and inducible nitric
oxide synthase in the kidney
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Hyperhomocysteinemia activates NF-jB and inducible nitric
oxide synthase in the kidney.
Background. Hyperhomocysteinemia is an independent risk
factor for cardiovascular disorders. Injury of multiple organs,
including the kidney, was observed in hyperhomocysteinemic
individuals. Activation of a transcription factor, namely, nuclear
factor kappa B (NF-jB), plays an important role in inflamma-
tory response and can exacerbate organ injury. The objective of
the present study was to investigate the effect of hyperhomo-
cysteinemia on renal NF-jB activation and the consequence of
such activation.
Methods. Hyperhomocysteinemia was induced in Sprague-
Dawley rats after 4 weeks of a high-methionine diet. Activation
of NF-jB was determined by electrophoretic mobility shift as-
say. Role of inhibitor protein IjBa was examined by Western
immunoblotting analysis.
Results. There was a significant increase in the level of phos-
phorylated IjBa protein in kidneys of hyperhomocysteinemic
rats. This resulted in a decrease in the IjBa protein level lead-
ing to NF-jB activation. As a consequence, the expression of
inducible nitric oxide synthase (iNOS) mRNA and protein was
significantly elevated in kidneys of hyperhomocysteinemic rats.
Increased nitric oxide production (150% of the control) resulted
in peroxynitrite formation in these kidneys. Pretreatment of rats
with a NF-jB inhibitor not only abolished NF-jB activation, but
also reversed hyperhomocysteinemia-induced iNOS expression
in the kidney.
Conclusion. Hyperhomocysteinemia alone can activate NF-
jB and hence induce iNOS-mediated nitric oxide production
in the kidney leading to increased peroxynitrite formation. This
may represent one of the mechanisms for renal dysfunction in
hyperhomocysteinemia.
Hyperhomocysteinemia is an independent risk factor
for cardiovascular diseases [1–4]. Abnormal elevations of
homocysteine levels up to 0.1 to 0.25 mmol/L in plasma
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have been reported in patients with hyperhomocysteine-
mia [5]. Factors that are responsible for the elevation of
plasma homocysteine levels include genetic deficiency of
enzymes necessary for homocysteine metabolism, folate
or vitamin B deficiency, impaired renal function, as well
as in elderly people and in postmenopausal women [1–4].
There is an inverse correlation between plasma levels of
homocysteine and renal function. In patients with chronic
renal failure, there is a marked elevation of plasma homo-
cysteine levels and a striking increase (up to 20-fold) in
the risk for vascular diseases [6]. Several potential mecha-
nisms responsible for the pathogenesis of hyperhomocys-
teinemia have been proposed. These include endothelial
dysfunction [7, 8], increased proliferation of smooth mus-
cle cells [9], enhanced coagulability [10], and increased
cholesterol biosynthesis in hepatocytes [11, 12].
In 1969, McCully [13] reported postmortem observa-
tion of extensive arteriosclerosis in two children with se-
vere hyperhomocysteinemia and proposed a pathogenic
link between elevated blood homocysteine levels and
atherogenesis. Apart from the cardiovascular findings,
the necropsy also revealed a moderate increase in mesan-
gial matrix as well as in the number of mesangial and
endothelial cells in the kidney [13]. A recent study re-
vealed that diet-induced hyperhomocysteinemia caused
vascular remodeling and tubulointerstitial injury in the
kidney [14]. Another study suggested that hyperhomo-
cysteinemia might be an important pathogenic factor for
glomerular damage in hypertensive animals independent
of blood pressure [15].
Many risk factors for cardiovascular disorders can also
induce inflammatory response in the kidney leading to
renal dysfunction/injury. Such response, due to changes
in gene expression, may be regulated by transcription fac-
tors. Recent studies suggest that one of these transcrip-
tion factors, namely, nuclear factor kappa B (NF-jB),
plays an important role in up-regulating the expression
of inflammatory factors in atherosclerotic lesions [16–
19]. We previously reported that enhanced chemokine
expression during renal ischemia/reperfusion injury was
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mediated via NF-jB activation [20]. NF-jB is normally
present in the cytoplasm in an inactive form that is asso-
ciated with an inhibitory protein, named IjB [16, 21, 22].
Upon stimulation by various NF-jB stimuli, IjBa (a well-
studied IjB protein) is rapidly phosphorylated leading
to ubiquitination and subsequent degradation of IjBa as
well as translocation of NF-jB to the nucleus (activated
NF-jB). The active NF-jB binds to the NF-jB binding
motifs in the promoters or enhancers of the genes encod-
ing cytokines and regulates their expression. In our recent
study, homocysteine was found to stimulate nitric oxide
production in monocyte-derived macrophage via NF-jB
activation [23]. Renal cells are capable of synthesizing ni-
tric oxide, a molecule that plays an important role in many
physiologic and pathologic processes. Renal function can
be perturbed by changes in the expression of nitric oxide
synthases (NOS) leading to imbalanced nitric oxide pro-
duction [24–26]. Three isoforms of NOS have been identi-
fied. These include constitutive endothelial NOS (eNOS),
inducible NOS (iNOS), and neuronal NOS (nNOS) [24–
26]. It is generally believed that the eNOS-derived nitric
oxide, at low concentrations, acts as a hemodynamic fac-
tor regulating vasodilatation. Contrary to the eNOS, the
iNOS in the kidney is mostly activated in pathologic con-
ditions [27, 28]. Excessive nitric oxide production due to
elevated expression of iNOS may impose cytotoxic effects
on various organs, including kidney [29, 30]. The nitric ox-
ide at high level can rapidly react with superoxide anion
to yield a potent oxidant, peroxynitrite (OONO−), that
in turn causes extensive protein tyrosine nitration [31].
The expression of iNOS is mainly controlled by the acti-
vation of its transcriptional factors, including NF-jB. We
previously observed that homocysteine, at pathophysio-
logic concentrations, was able to activate NF-jB causing
enhanced iNOS expression in macrophages [23].
Although renal dysfunction/failure is an important fac-
tor causing hyperhomocysteinemia, the effect of homo-
cysteine on renal function is largely unknown. The aim of
the present study was to investigate the effect of hyperho-
mocysteinemia on NF-jB activation and NOS expression
in the kidney.
METHODS
Induction of hyperhomocysteinemia in animal model
Male Sprague-Dawley rats (bred from stock supplied
by Charles River Laboratories, Wilmington, MA, USA)
aged 8 weeks were divided into three groups (N = 16
for each group) and maintained for 4 weeks on the fol-
lowing diets before experiments as previously described
[32]. Group 1 animals were fed with a regular diet (con-
trol) (PMI Rodent Diet 5001) (PMI Nutrition Interna-
tional, Indianapolis, IN, USA). Group 2 animals were fed
with a high-methionine diet, a regular diet plus 1.7% me-
thionine (wt/wt). Group 3 animals were fed with a high-
cysteine diet, which was a regular diet plus 1.2% cysteine
(wt/wt). This group was included to test the specificity of
homocysteine effect on NF-jB activation and NOS ex-
pression in the animal model. The plasma homocysteine
levels were measured with the IMx Homocysteine As-
say based on the fluorescence polarization immunoassay
technology (Abbott Diagnostics Division, Abbott Park,
IL, USA). Kidney function was assessed by serum cre-
atinine measurement (Sigma-Aldrich Corporation, St.
Louis, MO, USA).
Western immunoblotting analysis
Renal NOS protein levels were determined by a West-
ern immonoblotting analysis [33]. Briefly, kidney proteins
(100 lg/mL) were separated by electrophoresis on a 7.5%
sodium dodecyl sulfate (SDS) polyacrylamide gel. Pro-
teins on the gel were then transferred to a nitrocellu-
lose membrane. The specific NOS band was identified
by rabbit anti-iNOS, anti-eNOS, or anti-nNOS antibod-
ies (Transduction Laboratories, Lexington, KY, USA).
Horseradish peroxidase-conjugated secondary antibod-
ies (Bio-Rad Laboratories, Hercules, CA, USA) were
used to develop the membranes. For determination of
renal IjBa protein levels, tissue proteins were separated
by SDS polyacrylamide gel (12.5%) electrophoresis
(PAGE) followed by electrophoretic transfer of pro-
teins from the gel to a nitrocellulose membrane. The
membrane was probed with rabbit anti-IjBa polyclonal
antibodies or antiphospho-IjBa (Ser32) polyclonal
antibodies (New England Biolabs, Inc., Beverly, MA,
USA). The specific NOS protein, IjBa, or phospho-IjBa
protein bands were visualized using enhanced chemi-
luminescence (ECL) reagents and analyzed with a gel
documentation system (Bio-Rad Gel Doc1000 and Multi-
Analyst version 1.1) (Bio-Rad Laboratories).
Northern blot analysis
Total RNAs were isolated from the kidney tissue with
TriZol reagent (Invitrogen Life Technologies, Carlsbad,
CA, USA). The cDNA probes for iNOS (581 bp) and for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(516 bp) were generated by reverse transcription-
polymerase chain reaction (RT-PCR). The primers used
in the PCR reactions were synthesized by Invitrogen: for
iNOS, 5′-GTGGTGACAAGCACATTTGG-3′; 5′-GTC
TGGTTGCCTGGGAA-3′; and for GAPDH, 5′-AATG
CATCCTGC ACCACC AA-3′; and 5′-GTAGCCATA
TTCATTGTCATA-3′. The sequences of the cDNA
probes were identical to those deposited in the GenBank
(iNOS, D83661; GAPDH, X02231). The cDNA probes
were labeled with [a-32P] deoxyadenosine triphosphate
(dATP), using Prime-It II Random Primer Labeling kit
(Stratagene, Cedar Creek, TX, USA). The RNA (20 lg)
was separated by an agarose gel (1.2%) containing
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formaldehyde (2.2 mol/L) followed by transfer to a ny-
lon membrane (Schleicher & Schuell, Keene, NH, USA).
Northern hybridization was performed with denatured
[a-32P]-labeled cDNA probes. The membrane was ex-
posed to x-ray film and the resulting autoradiograph was
analyzed with a gel documentation system (Bio-Rad Gel
Doc1000 and Multi-Analyst version 1.1) (Bio-Rad Lab-
oratories). To correct for differences in gel loading, in-
tegrated optical densities were normalized to GAPDH.
Values were expressed as the relative expression of iNOS
mRNA normalized to GAPDH mRNA levels.
Measurement of nitric oxide in the kidney
The measurement of the stable end products of nitric
oxide metabolites, nitrite and nitrate was used to assess
nitric oxide level in the kidney. The amount of nitric ox-
ide metabolites was determined by modified assay based
on the Griess reaction as described by Cheung, Siow,
and O [33]. In brief, the kidney tissue was homogenized
in 20 mmol/L Tris buffer (pH 7.4) containing 2 mmol/L
ethylendiaminetetraacetic acid (EDTA) followed by cen-
trifugation at 600g for 10 minutes at 4◦C. The nitrate in
the supernatant (100 lL) was first converted to nitrite by
the action of the reduced form of nicotinamide adenine
dinucleotide phosphate (NADPH)-dependent nitrate re-
ductase. The Griess reaction was initiated by the addition
of a reagent that contained 1% sulfanilamide (wt/vol) and
0.1% N-(1-naphthyl)-ethylenediamine (wt/vol). The ab-
sorbency of the reaction mixture was read at 540 nm.
The concentration of nitrite/nitrate in the kidney was ex-
pressed as nmol per mg tissue protein.
Immunohistochemical staining
After diet treatment for 4 weeks, animals were sac-
rificed and kidney slices were immersion-fixed in 10%
neutral-buffered formalin overnight and then embedded
in paraffin. Sequential 5 lm paraffin-embedded sections
were immunostained by using rabbit polyclonal antibod-
ies (1:100) against rat iNOS (Calbiochem Novabiochem
International, Inc., San Diego, CA, USA). Endogenous
peroxidase was blocked with 0.3% H2O2 for 20 min-
utes. The secondary antibodies for immunostaining were
biotin-conjugated anti-rabbit immunoglobulins (1:200)
(Dako, Glostrup, Denmark). For detection of nitroty-
rosine protein adducts in the kidney, mouse antinitroty-
rosine antibody (1:100) was used (Zymed Laboratories,
Inc., San Francisco, CA, USA). The secondary antibodies
for immunostaining were biotin-conjugated antimouse
immunoglobulins (1:200) (Dako). After incubation with
streptavidin-horse radish peroxidase conjugate (Zymed
Laboratories, Inc.), visualization of peroxidase localiza-
tion was performed using diaminobenzidine-hydrogen
peroxide (DAB-H2O2) substrate to give a brown color.
For a negative control, normal rabbit IgG was used
Table 1. Plasma levels of homocysteine and creatinine and body
weight
Homocysteine Creatinine Body
Treatment lmol/L lmol/L weight g
Control 4.98 ± 0.92 37.72 ± 8.77 459 ± 30
Methionine 20.34 ± 2.76∗ 39.90 ± 9.46 450 ± 24
Cysteine 5.37 ± 1.04 38.84 ± 7.31 465 ± 34
Rats were divided into three groups (N = 16 for each group) fed with different
diet: regular diet (Control), high methionine diet (Methionine) or high cysteine
diet (Cysteine). ∗P < 0.05 compared with control values.
as primary antibody. For in situ detection of activated
NF-jB in the kidney, immunohistochemical staining with
primary antibodies against the activated p65 subunit of
NF-jB was carried out (Chemicon International, Temec-
ula, CA, USA). This mouse anti-NF-jB subunit mono-
clonal antibody recognized an epitope overlapping the
nuclear localization signal of the p65 subunit of the
NF-jB heterodimer. For a negative control, normal IgG
was used as primary antibody. The secondary antibod-
ies for immunostaining were biotinylated rabbit anti-
mouse Igs (Dako). After immunostaining, the slides
were counterstained with Harris’ hematoxylin. Bound
antibodies were viewed under light microscopy by us-
ing streptavidin-horseradish peroxidase conjugate in the
presence of H2O2.
Electrophoretic mobility shift assay (EMSA)
Nuclear proteins were isolated and EMSA was per-
formed to determine the NF-jB/DNA binding activity
[20]. In brief, nuclear proteins (10 lg) were incubated
with the reaction buffer for 15 minutes at room tem-
perature followed by incubation with 32P-end-labeled
oligonucleotide containing the consensus sequence for
the NF-jB/DNA binding site (5′-GGGGACTTTCC-3′)
(Invitrogen Life Technologies). The reaction mixture was
separated in a nondenaturing polyacrylamide gel (6%)
that was later exposed to x-ray film at −70◦C. The bind-
ing of labeled oligonucleotide to nuclear proteins was
blocked by adding unlabeled specific competitor oligonu-
cleotide to the reaction mixture. This was to confirm that
the binding of 32P-end-labeled oligonucleotide to NF-jB
was sequence-specific.
Statistical analysis
Results were analyzed using two-tailed Student t test.
The level of statistical significance was set at P < 0.05.
RESULTS
Induction of hyperhomocysteinemia in rats
Hyperhomocysteinemia was induced in rats fed with a
high methionine diet for 4 weeks. As shown in Table 1,
the high methionine diet resulted in a significant increase
in plasma homocysteine levels. The high cysteine diet did
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not affect plasma levels of homocysteine as compared
to the control values (Table 1). There was no significant
difference in the renal function as measured by serum
creatinine levels (Table 1). Furthermore, there were no
significant differences in body weights among rats fed
with different diets (Table 1).
Expression of NOS in the kidney
Western immunoblotting analysis was performed to
determine NOS protein levels in the kidney. As shown
in Figure 1A, the level of iNOS was significantly elevated
in kidneys isolated from rats fed with a high methion-
ine diet. In accordance with these results, the level of
renal iNOS mRNA (Fig. 1B) and the level of nitric oxide
(Fig. 1C) were significantly increased in the kidneys iso-
lated from rats fed with a high methionine diet. The levels
of iNOS protein, iNOS mRNA, and nitric oxide metabo-
lites in the kidneys isolated from rats fed with a high cys-
teine diet were similar to that of the control (Fig. 1). In
addition, there was no difference in the expression of
eNOS and nNOS among the kidneys isolated from rats
fed with different diets (data not shown). Next, the dis-
tribution of iNOS protein in the kidney was examined by
immunohistochemical staining. Compared to the control
group (Fig. 2A and B), the kidneys isolated from rats fed
with a high methionine diet (Fig. 2C and D) displayed
an increased staining for iNOS protein with a stronger
staining observed in the medulla (Fig. 2D). There was no
difference in the immunostaining for iNOS between kid-
neys of the control and the rats fed with a high cysteine
diet (Fig. 2E and F). The immunostaining was also per-
formed with a nonspecific primary antibody (IgG) and
no positive staining was observed (Fig. 2G and H).
Effect of homocysteine on NF-jB activation in the kidney
EMSA was performed to investigate whether NF-jB
activity was altered in the kidneys of rats fed with dif-
ferent diets. As shown in Figure 3A, the NF-jB/DNA
binding activity was significantly elevated in the kidneys
of rats fed with a high methionine diet. To investigate
whether NF-jB activation was due to increased degra-
dation of its inhibitor protein, Western immunoblotting
analysis was performed to determine the protein levels
of IjBa in the kidney. As shown in Figure 3B, the level
of IjBa protein was significantly reduced in the kid-
neys of rats fed with a high methionine diet. In corre-
spondence with these results, the level of phosphorylated
IjBa protein was markedly elevated in the same kidneys
indicating that increased phosphorylation of IjBa was
responsible for observed reduction of IjBa level in the
kidneys. There was no change in the NF-jB activity in
the kidneys of rats fed with a high cysteine diet (Fig. 3A).
The expression of IjBa mRNA was similar in the kid-
neys isolated from rats fed with different diets (data not
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Fig. 1. Expression of inducible nitric oxide synthase (iNOS) and the
content of nitric oxide (NO) metabolites in the kidney. Rats were fed
with following diets for 4 weeks (N = 16 for each group): a regular
diet (Control), a high methionine diet (Met), or a high cysteine diet
(Cysteine) and kidneys were isolated. (A) The iNOS protein levels
were determined by a Western immunoblotting analysis. (B) The iNOS
mRNA and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA were determined by a Northern blot analysis. (C) The levels
of nitric oxide metabolites (nitrite and nitrate) were determined in iso-
lated kidneys. Results were expressed as mean ± standard deviation
(error bar). ∗P < 0.05 compared with control values (the relative den-
sitometric units for the control iNOS protein or iNOS/GAPDH mRNA
ratio were expressed as 100).
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Fig. 2. Immunohistochemical analysis of in-
ducible nitric oxide synthase (iNOS) protein
in the kidney. Four weeks after rats were fed
with a regular diet (Control) (A and B), a
high methionine diet (Met) (C and D), or a
high cysteine diet (E and F), kidney slices
were fixed in 10% neutral-buffered formalin
overnight and then embedded in paraffin. Im-
munohistochemical staining for iNOS protein
was performed with anti-iNOS antibodies. Af-
ter counterstaining with hematoxylin, iNOS
protein was identified under light microscope
(magnification of 200×). As a negative con-
trol, immunohistochemical staining was per-
formed by using nonspecific IgG as a primary
antibody (G and H). Arrows point to iNOS
protein (in brown color).
shown). The involvement of NF-jB activation in iNOS
expression was further investigated by using NF-jB in-
hibitors N-acetylcysteine (NAC) and pyrrolidine dithio-
carbamate (PDTC) [20]. Pretreating rats with NAC or
PDTC not only blocked NF-jB activation (Fig. 4A),
but also completely abolished hyperhomocysteinemia-
induced iNOS mRNA expression in the kidneys
(Fig. 4B).
1332 Zhang et al: Hyperhomocysteinemia activates renal NF-jB
0
60
30
120
90
180
150
N
F-
κ
B/
DN
A
bi
nd
in
g 
ac
tiv
ity
,
%
 o
f c
on
tro
l
Control Met Cysteine
NF-κB
A
0
40
20
80
60
120
100
Iκ
Bα
,
%
 o
f c
on
tro
l
Control Met Cysteine
Control Met Cysteine
IκBα protein
B
0
40
20
80
60
120
100
Ph
os
ph
o-
Iκ
Bα
,
%
 o
f c
on
tro
l
*
C
*
*
Phospho-IκBα protein
Fig. 3. Effect of hyperhomocysteinemia on nuclear factor-kappaB
(NF-jB)/DNA binding activity and IjBa protein levels in the kidney.
Rats were fed with the same diets as described in Figure 1 for 4 weeks: a
regular diet (Control), a high methionine diet (Met), or a high-cysteine
diet (Cysteine). (A) Electrophoretic mobility shift assay (EMSA) was
performed to determine the NF-jB/DNA binding activity. The levels of
phospho-IjBa protein (B) and IjBa protein (C) were determined by
a Western immunoblotting analysis. Results were expressed as mean ±
standard deviation (error bar). ∗P < 0.05 compared with control values.
Increased nitrotyrosine formation during
hyperhomocysteinemia
Immunohistochemical staining for nitrotyrosine pro-
tein adducts was performed. As shown in Figure 5A and
B, little adduct formation was present in the kidney sec-
tions of the control rats. However, intensive staining was
observed in the kidney sections from rats fed with a high
methionine diet (Fig. 5C and D) with a stronger staining
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Fig. 4. Effect of nuclear factor-kappaB (NF-jB) inhibitors on NF-
jB/DNA binding activity and inducible nitric oxide synthase (iNOS)
expression in the kidney. Rats were fed with a regular diet (Control) or a
high methionine diet (Met) for 4 weeks. One group of rats fed with a high
methionine diet was treated with inhibitors of NF-jB [N-acetylcysteine
(NAC) 400 mg/kg or pyrrolidine dithiocarbamate (PDTC) 100 mg/kg]
by intraperitoneal injection 8 hours prior to the isolation of kidneys.
(A) Nuclear proteins were isolated from kidneys of rats fed with a reg-
ular diet (Control), a high methionine diet (Met) or rats fed with a high
methionine diet pretreated with NAC (Met + NAC) or PDTC (Met +
PDTC). Electrophoretic mobility shift assay (EMSA) was performed
to determine NF-jB/DNA binding activity. (B) In another set of ex-
periments, total RNA was prepared from kidneys of rats with same
treatment. The iNOS mRNA and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) mRNA were determined by a Northern blot
analysis. Representative results were obtained from three separate ex-
periments. Results were expressed as mean ± standard deviation (error
bar). ∗P < 0.05 compared with control values.
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Fig. 5. Immunohistochemical staining for ni-
trotyrosine protein adducts. Four weeks af-
ter rats were fed with a regular diet (Con-
trol) (A and B), a high methionine diet
(Met) (C and D), or a high cysteine diet
(E and F), kidney slices were fixed in 10%
neutral-buffered formalin overnight and then
embedded in paraffin. Immunohistochemical
staining for nitrotyrosine protein adducts was
performed with antinitrotyrosine antibod-
ies. After counterstaining with hematoxylin,
nitrotyrosine protein adducts were identi-
fied under light microscope (magnification of
200×). As a negative control, immunohis-
tochemical staining was performed by using
nonspecific IgG as a primary antibody (G and
H). Arrows point to nitrotyrosine protein (in
brown color).
for nitrotyrosine protein adducts in the medulla (Fig. 5D).
There was no difference in the intensity of immunos-
taining for adducts in the kidneys between the control
and the rats fed with a high cysteine diet (Fig. 5E and
F). The immunostaining was also performed with a non-
specific primary antibody (IgG) and no positive staining
was observed (Fig. 5G and H). To determine whether in-
creased iNOS expression in the kidney was due to infiltra-
tion of monocytes/macrophages, immunohistochemical
staining for monocytes/macrophages was performed with
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anti-endothelin-1 (ED-1) antibodies [20]. Few ED-1–
positive cells were detected in the kidneys isolated from
rats fed with different diets (data not shown). These
results suggested that hyperhomocysteinemia-induced
iNOS expression occurred in renal cells leading to per-
oxynitrite formation in the kidney.
Effect of NF-jB inhibitor on iNOS expression
Immunohistochemical analysis was carried out to de-
tect the activation of NF-jB in the kidney. As shown in
Figure 6, the immunostaining for the activated form of
NF-jB was not evident in kidneys isolated from control
rats. A stronger staining was observed in the medulla
of kidneys isolated from rats fed with a high methion-
ine diet. Although there was mild immunostaining for
the activated form of NF-jB in the tubules of the cor-
tex, little was detected in glomeruli of kidneys isolated
from rats fed with a high methionine diet. To further ex-
amine the relationship between NF-jB activation and
iNOS expression during hyperhomocysteinemia, an in-
hibitor of NF-jB activation, PDTC was administered to
rats intraperitoneally [20]. After PDTC treatment, the
intensity of immunostaining for the activated form of
NF-jB was markedly reduced in the kidneys isolated
from rats fed with a high methionine diet (Fig. 6). Im-
munostaining analysis was also carried out to exam-
ine the effect of NF-jB inhibitor on the distribution
of iNOS protein in the kidney. As shown in Figure 7,
an increased staining for iNOS protein was observed
in the medulla of kidneys isolated from rats fed with a
high methionine diet with a stronger staining observed
in the medulla. PDTC treatment significantly inhibited
hyperhomocysteinemia-induced iNOS expression in the
kidney (Fig. 7). The immunostaining was also performed
with nonspecific primary antibody (IgG) and no posi-
tive staining was observed (Figs. 6 and 7). These results
suggested that hyperhomocysteinemia-induced iNOS ex-
pression was mediated via activation of NF-jB.
DISCUSSION
The present study has clearly demonstrated that [1]
diet-induced hyperhomocysteinemia activates NF-jB in
rat kidney via increased phosphorylation of IjBa; [2]
activation of NF-jB causes up-regulation of iNOS ex-
pression leading to enhanced nitric oxide production and
peroxynitrite formation in the kidneys. In view that a high
cysteine diet did not result in any change in the renal
NF-jB activity nor NOS expression, the increased nitric
oxide production observed in the kidneys of rats fed with
a high methionine diet was related specifically to hyper-
homocysteinemia.
The expression of iNOS is regulated by many fac-
tors at the transcription level. NF-jB is considered as
an important transcription factor in regulating iNOS ex-
pression. Evidence obtained from our previous studies
indicated that NF-jB might play an important role in
homocysteine-induced chemokine expression [34, 35].
In these studies, activation of NF-jB by homocysteine
was observed in cultured macrophages [34] as well as in
vascular smooth muscle cells [35] leading to increased
chemokine expression. Furthermore, we observed
that homocysteine treatment also activated NF-jB
in monocyte-derived macrophages causing increased
iNOS-mediated nitric oxide production [23]. The present
study was the first to reveal that NF-jB activity was signif-
icantly increased in the kidney of hyperhomocysteinemic
rats. The possible mechanism of NF-jB activation in the
kidney was further investigated. It is generally believed
that phosphorylation of IjBa at serine residue (Ser32,
Ser36) is essential for IjBa degradation and subsequent
release of active NF-jB. In the present study, an increase
in the level of serine phosphorylated IjBa protein was
observed in the kidneys of hyperhomocysteinemic rats.
As phosphorylated IjBa was rapidly ubiquitinated and
degraded by 26S proteasome complex leading to de-
creased levels of IjBa and subsequent dissociation of
NF-jB, free NF-jB could translocate into the nucleus and
bind to the NF-jB site on the promoter region of iNOS
gene, regulating its expression. The activation of NF-jB
has been shown in the atherosclerotic lesions [17] and in
other organs including kidney after ischemia/reperfusion
injury [20]. However, it is not clear if the activation of NF-
jB plays a causative role in iNOS expression in the kidney
during hyperhomocysteinemia. Evidence obtained from
the present study indicated that NF-jB activation was
involved in homocysteine-induced iNOS expression in
the kidney. Pretreatment with NF-jB inhibitors (PDTC
or NAC) not only blocked NF-jB activation but also
abolished hyperhomocysteinemia-induced iNOS mRNA
expression in the kidney. Taken together, these results
indicate that NF-jB activation plays an important role in
renal iNOS expression during hyperhomocysteinemia.
Nitric oxide plays an important role in a variety of
physiologic and pathophysiologic processes in the kid-
ney [27, 28]. Nitric oxide can interact with reactive oxy-
gen species to form peroxynitrite, which induces protein
damage by formation of nitrotyrosine. It is generally be-
lieved that the eNOS-derived nitric oxide, in low levels,
regulates the physiologic vasodilatation while excess ni-
tric oxide production due to elevated expression of iNOS
may pose cytotoxic effects to the surrounding cells. Renal
function can be perturbed by changes in the nitric oxide
production in the kidney. The contribution of nitric ox-
ide to tissue injury can be due to direct effect mediated
by the nitric oxide molecule itself [36] and an indirect
effect mediated by reactive nitrogen species produced
by the interaction of nitric oxide with superoxide anions
or oxygen [36, 37]. For example, iNOS-mediated nitric
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Cortex Medulla
Fig. 6. Immunohistochemical staining of ac-
tivated form of nuclear factor-kappaB (NF-
jB) in the kidney. Rats were fed with a regular
diet (Control) (A and B) or a high methion-
ine diet (Met) (C and D) for 4 weeks. One
group of rats fed with a high methionine diet
was treated with pyrrolidine dithiocarbamate
(PDTC) (100 mg/kg) by intraperitoneal injec-
tion 8 hours prior to the isolation of kidneys
(Met + PDTC) (E and F). The kidney slices
were fixed in 10% neutral-buffered formalin
overnight and then embedded in paraffin. Im-
munohistochemical staining for the activated
form of NF-jB was performed. After counter-
staining with hematoxylin, activated form of
NF-jB was identified under light microscope
(magnification of 200×). As a negative con-
trol, immunohistochemical staining was per-
formed by using nonspecific IgG as a primary
antibody (G and H). Arrows point to the ac-
tivated form of NF-jB (in brown color).
oxide production was significantly elevated during renal
ischemia/reperfusion injury [27–29, 38, 39]. Once pro-
duced, nitric oxide can interact with superoxide anions to
form peroxynitrite. It has been suggested that peroxyni-
trite can be decomposed into more potent oxidant species
namely hydroxyl radical and nitrogen dioxide [31]. On
the other hand, peroxynitrite is able to nitrate tyrosine
residues of proteins [39]. Nitrotyrosine/nitrated proteins
have been detected in atherosclerotic plaques [40] as well
as in renal allograft [41]. In the present study, renal ni-
trotyrosine staining was markedly elevated suggesting
that peroxynitrite was formed in the kidneys of hyper-
homocysteinemic rats. Infiltrated macrophages were un-
likely to be a source of peroxynitrite formation because
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Fig. 7. Effect of nuclear factor-kappaB (NF-
jB) inhibitor on inducible nitric oxide
synthase (iNOS) protein distribution in the
kidney. Rats were fed with a regular diet
(Control) (A and B) or a high methion-
ine diet (Met) (C and D) for 4 weeks. One
group of rats fed with a high methionine diet
was treated with pyrrolidine dithiocarbamate
(PDTC) (100 mg/kg) by intraperitoneal in-
jection 8 hours prior to the isolation of kid-
neys (Met + PDTC) (E and F). The kidney
slices were fixed in 10% neutral-buffered for-
malin overnight and then embedded in paraf-
fin. Immunohistochemical staining for iNOS
protein was performed. After counterstain-
ing with hematoxylin, iNOS protein was iden-
tified under light microscope (magnification
of 200×). As a negative control, immunohis-
tochemical staining was performed by using
non-specific IgG as a primary antibody (G and
H). Arrows point to iNOS protein (in brown
color).
few ED-1–positive cells were detected in the kidneys of
rats with hyperhomocysteinemia. The pathophysiologic
consequences of increased formation of peroxynitrite and
nitrotyrosine during hyperhomocysteinemia remain to be
established.
Hyperhomocysteinemia is a chronic disorder that cor-
relates positively with the development of atherosclerosis
due to inflammatory responses. The impact of elevated
plasma homocysteine levels on the kidney is largely
unknown. McCully [13] first reported the pathologic
changes in the kidney of children with severe hyperho-
mocysteinemia. In a recent study, Kumagai et al [14]
reported that hyperhomocysteinemia was induced in
weanling Fisher rats by 12-week dietary combinations
including folate deficiency, methionine loading, and
choline deficiency. In this hyperhomocysteinemic model,
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tubulointerstitial fibrosis developed in the cortex of the
kidney with increased expression of endothelial growth
factor. Another recent study demonstrated that 8-week
homocysteine-thiolactone administration induced hyper-
homocysteinemia leading to oxidative stress and im-
paired renal function in Wistar rats [30]. In the present
study, short-term hyperhomocysteinemia (4 weeks) was
induced in rats fed with a high methionine diet. Although
there was neither functional alteration nor visible mor-
phologic changes in kidneys isolated from hyperhomo-
cysteinemic rats, biochemical and molecular biological
analysis of the kidneys revealed a significant elevation in
iNOS expression and NF-jB activation. The activation
of NF-jB and up-regulation of iNOS have been found to
contribute to inflammatory responses in renal and cardio-
vascular disorders. We speculate that NF-jB activation
and increased iNOS expression may lead to pathologic
and functional changes in the kidneys after prolonged
exposure to elevated plasma homocysteine levels.
CONCLUSION
This study, for the first time, demonstrates that
hyperhomocysteinemia alone can activate NF-jB
and induce iNOS expression in the kidney leading
to increased peroxynitrite formation. Homocysteine-
stimulated nitric oxide production via iNOS may
represent one of the mechanisms for renal dysfunction in
hyperhomocysteinemia.
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